DK0445743T3 - - Google Patents

Info

Publication number
DK0445743T3
DK0445743T3 DK91103336.3T DK91103336T DK0445743T3 DK 0445743 T3 DK0445743 T3 DK 0445743T3 DK 91103336 T DK91103336 T DK 91103336T DK 0445743 T3 DK0445743 T3 DK 0445743T3
Authority
DK
Denmark
Prior art keywords
resp
chelates
bivalent
antibiotics
obtaining
Prior art date
Application number
DK91103336.3T
Other languages
Danish (da)
English (en)
Inventor
Slobodan Djokic
Zlatko Vajtner
Hrvoje Krnjevic
Nevenka Lopotar
Lidija Kolacny-Babic
Original Assignee
Pliva Pharm & Chem Works
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pliva Pharm & Chem Works filed Critical Pliva Pharm & Chem Works
Application granted granted Critical
Publication of DK0445743T3 publication Critical patent/DK0445743T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/06Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/60Salicylic acid; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/26Iron; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H23/00Compounds containing boron, silicon or a metal, e.g. chelates or vitamin B12
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK91103336.3T 1990-03-07 1991-03-05 DK0445743T3 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
YU45590A YU45590A (sh) 1990-03-07 1990-03-07 Novi kompleksi odnosno helati antibiotika s dvovalentnim i/ili trovalentnim metalima i postupci za njihovo dobijanje

Publications (1)

Publication Number Publication Date
DK0445743T3 true DK0445743T3 (fr) 1997-02-17

Family

ID=25550003

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91103336.3T DK0445743T3 (fr) 1990-03-07 1991-03-05

Country Status (20)

Country Link
US (1) US5498699A (fr)
EP (1) EP0445743B1 (fr)
JP (1) JP2731636B2 (fr)
CN (2) CN1041166C (fr)
AT (1) ATE143266T1 (fr)
BG (1) BG61230B1 (fr)
CA (1) CA2037663C (fr)
CZ (1) CZ280181B6 (fr)
DE (1) DE69122282T2 (fr)
DK (1) DK0445743T3 (fr)
ES (1) ES2094763T3 (fr)
GR (1) GR3021947T3 (fr)
HR (1) HRP940256B1 (fr)
HU (2) HU209455B (fr)
PL (1) PL166279B1 (fr)
RO (1) RO107660B1 (fr)
RU (2) RU2039060C1 (fr)
SI (1) SI9010455B (fr)
SK (1) SK279278B6 (fr)
YU (1) YU45590A (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2064634C (fr) * 1991-04-04 1998-08-04 James V. Heck Derives de 9-desoxo-8a-aza-8a-homoerythromycine a modifies en positions 4"- et 8a
GB9120131D0 (en) * 1991-09-20 1991-11-06 Glaxo Group Ltd Medicaments
TW271400B (fr) * 1992-07-30 1996-03-01 Pfizer
GB9501560D0 (en) 1995-01-26 1995-03-15 Nycomed Imaging As Contrast agents
JPH10512877A (ja) * 1995-01-26 1998-12-08 ニコムド イメージング エイ/エス ビスマス化合物
US5900410A (en) * 1996-08-27 1999-05-04 Hartmann; John F. Monotherapy of peptic ulcers and gastritis
US6861411B1 (en) 1997-12-02 2005-03-01 Pfizer, Inc. Method of treating eye infections with azithromycin
US7056893B2 (en) 1999-03-31 2006-06-06 Insite Vision, Inc. Topical treatment for prevention of ocular infections
US6239113B1 (en) 1999-03-31 2001-05-29 Insite Vision, Incorporated Topical treatment or prevention of ocular infections
HRP20010301A2 (en) * 2001-04-27 2001-12-31 Pliva D D New therapeutic indication for azithromycin in the treatment of non-infective inflammatory diseases
EP1671979B1 (fr) 2001-05-22 2008-08-13 Pfizer Products Inc. Nouvelle forme cristalline de l'azithromycine
HRP20040163A2 (en) * 2001-08-21 2005-02-28 Pfizer Products Inc. Single dose azithromycin for treating respiratory infections
RU2283116C2 (ru) * 2002-05-27 2006-09-10 Курский государственный медицинский университет Способ увеличения выживаемости изолированного кожного лоскута "на ножке" у животных с пониженным антиоксидантным фоном
US7468428B2 (en) 2004-03-17 2008-12-23 App Pharmaceuticals, Llc Lyophilized azithromycin formulation
US20060046970A1 (en) * 2004-08-31 2006-03-02 Insite Vision Incorporated Topical otic compositions and methods of topical treatment of prevention of otic infections
WO2006047671A2 (fr) 2004-10-25 2006-05-04 Paratek Pharmaceuticals, Inc. 4-aminotetracyclines et procedes d'utilisation
US8440646B1 (en) 2006-10-11 2013-05-14 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds for treatment of Bacillus anthracis infections
CN104892694A (zh) * 2015-05-24 2015-09-09 广西师范学院 蔗糖硫酸酯铜类化合物及其制作方法和用途

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3862225A (en) * 1961-08-18 1975-01-21 Pfizer D-ring substituted tetracyclines
US3622627A (en) * 1967-09-13 1971-11-23 Pfizer 4-dedimethylaminatetracycline and 5a, 6-anhydro derivatives thereof
HU167946B (fr) * 1973-04-16 1976-01-28
SI8110592A8 (en) * 1981-03-06 1996-06-30 Pliva Pharm & Chem Works Process for preparing of n-methyl-11-aza-10-deoxo-10-dihydroerythromycine a and derivatives thereof
EP0222834A4 (fr) * 1985-04-18 1989-10-04 Borody Thomas J Traitement de la dyspepsie non ulcereuse avec des sels de bismuth.
EP0206625B1 (fr) * 1985-06-13 1992-09-30 Barry James Dr. Marshall Composés pour le traitement d'affections gastro-intestinales
IT1200774B (it) * 1985-10-10 1989-01-27 Pierrel Spa Procedimento di sentisi dell'amikacina
YU44599B (en) * 1986-09-12 1990-10-31 Pliva Pharm & Chem Works Process for preparing complex of n-methyl-11-aza-10-deoxo-10-dihydroeritromicine a and 11-aza-10-deoxo-10-dihydroeritromicine a with metals
EP0283055B1 (fr) * 1987-09-03 1990-08-29 SOUR PLIVA farmaceutska, Kemijska prehrambena i kozmeticka industrija, n.sol.o. Dérivés de 10-dihydro-10-déoxo-11-azaérythronolide-A, procédés et intermédiaires pour leur préparation et leur utilisation dans et pour la préparation de médicaments
US5196205A (en) * 1987-10-12 1993-03-23 Borody Thomas J Method for treatment of gastro intestinal disorders
US5246708A (en) * 1987-10-28 1993-09-21 Pro-Neuron, Inc. Methods for promoting wound healing with deoxyribonucleosides
EP0391005B1 (fr) * 1989-04-03 1991-10-16 Ranbaxy Laboratories, Ltd. Procédé de préparation d'alpha-6-déoxytétracyclines
US5348946A (en) * 1991-02-28 1994-09-20 Biochem Immunosystems, Inc. Heteroanthracycline antitumor analogs
MA28714B1 (fr) * 2005-12-15 2007-07-02 Green Technlology Sarl Une arabinogalactane proteine ayant la propriete d'absorber les graisses et le procede d'obtention de cette arabinogalactane proteine

Also Published As

Publication number Publication date
JP2731636B2 (ja) 1998-03-25
ATE143266T1 (de) 1996-10-15
HU910740D0 (en) 1991-09-30
RU2039060C1 (ru) 1995-07-09
HU209455B (en) 1994-06-28
HUT56849A (en) 1991-10-28
CA2037663C (fr) 1999-01-19
RU2039061C1 (ru) 1995-07-09
CS9100587A2 (en) 1991-10-15
BG93995A (bg) 1993-12-24
YU45590A (sh) 1992-07-20
PL166279B1 (pl) 1995-04-28
US5498699A (en) 1996-03-12
SI9010455A (en) 1997-08-31
SK279278B6 (sk) 1998-09-09
CA2037663A1 (fr) 1991-09-08
HRP940256B1 (en) 1998-10-31
EP0445743A2 (fr) 1991-09-11
HU211475A9 (en) 1995-11-28
DE69122282T2 (de) 1997-04-24
CN1041166C (zh) 1998-12-16
CZ280181B6 (cs) 1995-11-15
RO107660B1 (ro) 1993-12-30
HRP940256A2 (en) 1997-06-30
SI9010455B (sl) 2000-04-30
BG61230B1 (bg) 1997-03-31
EP0445743A3 (en) 1992-10-07
CN1054534A (zh) 1991-09-18
DE69122282D1 (de) 1996-10-31
GR3021947T3 (en) 1997-03-31
EP0445743B1 (fr) 1996-09-25
JPH06184186A (ja) 1994-07-05
CN1168891A (zh) 1997-12-31
ES2094763T3 (es) 1997-02-01
CN1051560C (zh) 2000-04-19

Similar Documents

Publication Publication Date Title
EP0445743A3 (en) Complexes and chelates of azithromycin as antiulcer drugs
ZA878952B (en) Metal complex-containing pharmaceutical agents
GEP20074095B (en) Analogs of human insulin modified at position 29 of the b chain thereof
IL100942A0 (en) 2,4-diaminoquinazoline derivatives for enhancing antitumor activity
DE59005156D1 (de) Gleitbacke für Schiebedächer, Schiebehebedächer und dergleichen.
IL97463A0 (en) Pharmaceutical composition for treating emotional numbness
FI972287L (fi) Uudenlaisia polysubstituoituja DTPA-johdoksia ja niiden metallikomplekseja, kyseisiä komplekseja sisältäviä farmaseuttisia aineita, niiden käyttö diagnosoinnissa ja terapiassa sekä menetelmiä kyseisten kompleksinmuodostajien ja kompleksien valmistamiseksi ja menetelmiä kyseisten.
DE69016390D1 (de) Nitrierofen.
DE69101105D1 (de) Cis-platin-komplexe mit chelatierenden aminen und sulfinylcarboxylaten.
GB2239013B (en) Novel isoindole derivatives and salts thereof,processes for producing the same and antitumor agent comprising the same
NO882012L (no) Antitumor-platinakomplekser og fremgangsmaate til fremstilling derav.
ATE180148T1 (de) Differentialauszug für schubladen od.dgl.
GB2208620B (en) Seals between ceramic articles or between ceramic articles and metal articles.
DE69011806D1 (de) Gesinterter Glas-Keramikkörper und Verfahren.
DE68912818D1 (de) Antitumormittel.
DE3773180D1 (de) Vorrichtung zum verhindern des aushaengens von schiebetuerlaufrollen.
ZA921717B (en) Chelates,their metal complexes as well as their use in diagnosis and treatment
DE69014793D1 (de) Gesinterter keramischer Verbundkörper und Verfahren zu seiner Herstellung.
DE69103919D1 (de) Diaminoverbindungen und Vorstufe dafür.
ZA949604B (en) Haloaryl-substituted metal complexes pharmaceutical agents containing these complexes, their use in diagnosis, as well as process for the production of the complexes and agents
DE69101652D1 (de) Behandlungsofen.
EP0409527A3 (en) Cis-diamineplatinum complexes with methanediphosphonate and substituted methanediphosphonate ligands as antitumor agents
DE59100310D1 (de) Fördervorrichtung für Blechtafeln od. dgl.
ZA883975B (en) Treatment and diagnosis of footrot using the basic protease of b.nodosus
DE3851054D1 (de) Antitumor 6-sulfenamid, 6-sulfinamid und 6-sulfonamid-purine, purin-nukleoside, purin-nukleotide und verwandte verbindungen.